Abstract
Valproic acid (VPA), widely used for the treatment of neurological disorders, has anti-fibrotic activity by reducing collagen production in the postoperative conjunctiva. In this study, we investigated the capacity of VPA to modulate the postoperative collagen architecture. Histochemical examination revealed that VPA treatment was associated with the formation of thinner collagen fibers in the postoperative days 7 and 14 scars. At the micrometer scale, measurements by quantitative multiphoton microscopy indicated that VPA reduced mean collagen fiber thickness by 1.25-fold. At the nanometer scale, collagen fibril thickness and diameter measured by transmission electron microscopy were decreased by 1.08- and 1.20-fold, respectively. Moreover, delicate filamentous structures in random aggregates or closely associated with collagen fibrils were frequently observed in VPA-treated tissue. At the molecular level, VPA reduced Col1a1 but induced Matn2, Matn3, and Matn4 in the postoperative day 7 conjunctival tissue. Elevation of matrilin protein expression induced by VPA was sustained till at least postoperative day 14. In primary conjunctival fibroblasts, Matn2 expression was resistant to both VPA and TGF-β2, Matn3 was sensitive to both VPA and TGF-β2 individually and synergistically, while Matn4 was modulable by VPA but not TGF-β2. MATN2, MATN3, and MATN4 localized in close association with COL1A1 in the postoperative conjunctiva. These data indicate that VPA has the capacity to reduce collagen fiber thickness and potentially collagen assembly, in association with matrilin upregulation. These properties suggest potential VPA application for the prevention of fibrotic progression in the postoperative conjunctiva.
Key messages
-
VPA reduces collagen fiber and fibril thickness in the postoperative scar.
-
VPA disrupts collagen fiber assembly in conjunctival wound healing.
-
VPA induces MATN2, MATN3, and MATN4 in the postoperative scar.
Similar content being viewed by others
Data availability
Not applicable.
References
Xue M, Jackson CJ (2015) Extracellular matrix reorganization during wound healing and its impact on abnormal scarring. Adv Wound Care (New Rochelle) 4:119–136. https://doi.org/10.1089/wound.2013.0485
Herrera J, Henke CA, Bitterman PB (2018) Extracellular matrix as a driver of progressive fibrosis. J Clin Invest 128:45–53. https://doi.org/10.1172/JCI93557
Tschumperlin DJ, Ligresti G, Hilscher MB, Shah VH (2018) Mechanosensing and fibrosis. J Clin Invest 128:74–84. https://doi.org/10.1172/JCI93561
Jones MG, Andriotis OG, Roberts JJ, Lunn K, Tear VJ, Cao L, Ask K, Smart DE, Bonfanti A, Johnson P et al (2018) Nanoscale dysregulation of collagen structure-function disrupts mechano-homeostasis and mediates pulmonary fibrosis. Elife 7:e36354. https://doi.org/10.7554/eLife.36354
Brauer E, Lippens E, Klein O, Nebrich G, Schreivogel S, Korus G, Duda GN, Petersen A (2019) Collagen fibrils mechanically contribute to tissue contraction in an in vitro wound healing scenario. Adv Sci (Weinh) 6:1801780. https://doi.org/10.1002/advs.201801780
Cairns JE (1968) Trabeculectomy. Preliminary report of a new method. Am J Ophthalmol 66:673–679
Skuta GL, Parrish RK 2nd (1987) Wound healing in glaucoma filtering surgery. Surv Ophthalmol 32:149–170. https://doi.org/10.1016/0039-6257(87)90091-9
Wang D, Jampel HD (2018) Imprecision medicine: the use of mitomycin C in trabeculectomy surgery. Ophthalmol Glaucoma 1:149–151. https://doi.org/10.1016/j.ogla.2018.10.004
Seet LF, Toh LZ, Finger SN, Chu SW, Stefanovic B, Wong TT (2016) Valproic acid suppresses collagen by selective regulation of Smads in conjunctival fibrosis. J Mol Med (Berl) 94:321–334. https://doi.org/10.1007/s00109-015-1358-z
Seet LF, Toh LZ, Finger SN, Chu SWL, Wong TT (2019) Valproic acid exerts specific cellular and molecular anti-inflammatory effects in post-operative conjunctiva. J Mol Med (Berl) 97:63–75. https://doi.org/10.1007/s00109-018-1722-x
Yap ZL, Seet LF, Chu SW, Toh LZ, Ibrahim FI, Wong TT (2021) Effect of valproic acid on functional bleb morphology in a rabbit model of minimally invasive surgery. Br J Ophthalmol 2020:318691. https://doi.org/10.1136/bjophthalmol-2020-318691
Löscher W (2002) Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy. CNS Drugs 16:669–694. https://doi.org/10.2165/00023210-200216100-00003
Chateauvieux S, Morceau F, Dicato M, Diederich M (2010) Molecular and therapeutic potential and toxicity of valproic acid. J Biomed Biotechnol 2010:479364. https://doi.org/10.1155/2010/479364
Seet LF, Su R, Barathi VA, Lee WS, Poh R, Heng YM, Manser E, Vithana EN, Aung T, Weaver M et al (2010) SPARC deficiency results in improved surgical survival in a novel mouse model of glaucoma filtration surgery. PLoS ONE 5:e9415. https://doi.org/10.1371/journal.pone.0009415
Seet LF, Lee WS, Su R, Finger SN, Crowston JG, Wong TT (2011) Validation of the glaucoma filtration surgical mouse model for antifibrotic drug evaluation. Mol Med 17:557–567. https://doi.org/10.2119/molmed.2010.00188
Seet LF, Chu SWL, Teng X, Toh LZ, Wong TT (2020) Assessment of progressive alterations in collagen organization in the postoperative conjunctiva by multiphoton microscopy. Biomed Opt Express 11:6495–6515. https://doi.org/10.1364/BOE.403555
Ho H, Htoon HM, Yam GH, Toh LZ, Lwin NC, Chu S, Lee YS, Wong TT, Seet LF (2017) Altered anterior segment biometric parameters in mice deficient in SPARC. Invest Ophthalmol Vis Sci 58:386–393. https://doi.org/10.1167/iovs.16-20261
Seet LF, Toh LZ, Chu SWL, Finger SN, Chua JLL, Wong TT (2017) Upregulation of distinct collagen transcripts in post-surgery scar tissue: a study of conjunctival fibrosis. Dis Model Mech 10:751–760. https://doi.org/10.1242/dmm.028555
Klatt AR, Becker AK, Neacsu CD, Paulsson M, Wagener R (2011) The matrilins: modulators of extracellular matrix assembly. Int J Biochem Cell Biol 43:320–330. https://doi.org/10.1016/j.biocel.2010.12.010
Seet LF, Finger SN, Chu SW, Toh LZ, Wong TT (2013) Novel insight into the inflammatory and cellular responses following experimental glaucoma surgery: a roadmap for inhibiting fibrosis. Curr Mol Med 13:911–928. https://doi.org/10.2174/15665240113139990021
Andersen CL, Jensen JL, Orntoft TF (2004) Normalization of real-time quantitative reverse transcription-PCR data, a model-based variance estimation approach to identify genes suited for normalization applied to bladder and colon cancer data sets. Cancer Res 64:5245–5250. https://doi.org/10.1158/0008-5472.CAN-04-0496
Crowston JG (2008) Long-term outcomes of trabeculectomy. Clin Exp Ophthalmol 36:705–706. https://doi.org/10.1111/j.1442-9071.2008.01893.x
Christiansen DL, Huang EK, Silver FH (2000) Assembly of type I collagen: fusion of fibril subunits and the influence of fibril diameter on mechanical properties. Matrix Biol 19:409–420. https://doi.org/10.1016/s0945-053x(00)00089-5
Chakravarti S, Magnuson T, Lass JH, Jepsen KJ, LaMantia C, Carroll H (1998) Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican. J Cell Biol 141:1277–1286. https://doi.org/10.1083/jcb.141.5.1277
Raspanti M, Viola M, Sonaggere M, Tira ME, Tenni R (2007) Collagen fibril structure is affected by collagen concentration and decorin. Biomacromol 8:2087–2091. https://doi.org/10.1021/bm070091t
Rentsendorj O, Nagy A, Sinko I, Daraba A, Barta E, Kiss I (2005) Highly conserved proximal promoter element harbouring paired Sox9-binding sites contributes to the tissue- and developmental stage-specific activity of the matrilin-1 gene. Biochem J 389:705–716. https://doi.org/10.1042/BJ20050214
Szabó E, Korpos E, Batmunkh E, Lotz G, Holczbauer A, Kovalszky I, Deák F, Kiss I, Schaff Z, Kiss A (2008) Expression of matrilin-2 in liver cirrhosis and hepatocellular carcinoma. Pathol Oncol Res 14:15–22. https://doi.org/10.1007/s12253-008-9005-4
Chen C, Wei X, Ling J, Xie N (2011) Expression of matrilin-2 and -4 in human dental pulps during dentin-pulp complex wound healing. J Endod 37:642–649. https://doi.org/10.1016/j.joen.2011.02.018
Deák F, Mátés L, Korpos E, Zvara A, Szénási T, Kiricsi M, Mendler L, Keller-Pintér A, Ozsvári B, Juhász H et al (2014) Extracellular deposition of matrilin-2 controls the timing of the myogenic program during muscle regeneration. J Cell Sci 127(Pt 15):3240–3256. https://doi.org/10.1242/jcs.141556
Korpos É, Deák F, Kiss I (2015) Matrilin-2 an extracellular adaptor protein is needed for the regeneration of muscle nerve and other tissues. Neural Regen Res 10:866–869. https://doi.org/10.4103/1673-5374.158332
Ichikawa T, Suenaga Y, Koda T, Ozaki T, Nakagawara A (2008) ΔNp63/BMP-7-dependent expression of matrilin-2 is involved in keratinocyte migration in response to wounding. Biochem Biophys Res Commun 369:994–1000. https://doi.org/10.1016/j.bbrc.2008.02.128
Raja E, Komuro A, Tanabe R, Sakai S, Ino Y, Saito N, Todo T, Morikawa M, Aburatani H, Koinuma D et al (2017) Bone morphogenetic protein signaling mediated by ALK-2 and DLX2 regulates apoptosis in glioma-initiating cells. Oncogene 36:4963–4974. https://doi.org/10.1038/onc.2017.112
Andreev K, Zenkel M, Kruse F, Jünemann A, Schlötzer-Schrehardt U (2006) Expression of bone morphogenetic proteins (BMPs) their receptors and activins in normal and scarred conjunctiva: role of BMP-6 and activin-A in conjunctival scarring? Exp Eye Res 83:1162–1170. https://doi.org/10.1016/j.exer.2006.06.003
Sixto-López Y, Bello M, Correa-Basurto J (2020) Exploring the inhibitory activity of valproic acid against the HDAC family using an MMGBSA approach. J Comput Aided Mol Des 34:857–878. https://doi.org/10.1007/s10822-020-00304-2
Sun J, Piao J, Li N, Yang Y, Kim KY, Lin Z (2020) Valproic acid targets HDAC1/2 and HDAC1/PTEN/Akt signalling to inhibit cell proliferation via the induction of autophagy in gastric cancer. FEBS J 287:2118–2133. https://doi.org/10.1111/febs.15122
Lee BS, Kim YS, Kim HJ, Kim DH, Won HR, Kim YS, Kim CH (2018) HDAC4 degradation by combined TRAIL and valproic acid treatment induces apoptotic cell death of TRAIL-resistant head and neck cancer cells. Sci Rep 8:12520. https://doi.org/10.1038/s41598-018-31039-8
Wang H, Zhang H, Sun Q, Yang J, Zeng C, Ding C, Cai D, Liu A, Bai X (2019) Chondrocyte mTORC1 activation stimulates miR-483-5p via HDAC4 in osteoarthritis progression. J Cell Physiol 234:2730–2740. https://doi.org/10.1002/jcp.27088
Frank S, Schulthess T, Landwehr R, Lustig A, Mini T, Jenö P, Engel J, Kammerer RA (2002) Characterization of the matrilin coiled-coil domains reveals seven novel isoforms. J Biol Chem 277:19071–19079. https://doi.org/10.1074/jbc.M202146200
Chen Q, Zhang Y, Johnson DM, Goetinck PF (1999) Assembly of a novel cartilage matrix protein filamentous network: molecular basis of differential requirement of von Willebrand factor A domains. Mol Biol Cell 10:2149–2162. https://doi.org/10.1091/mbc.10.7.2149
Klatt AR, Nitsche DP, Kobbe B, Morgelin M, Paulsson M, Wagener R (2000) Molecular structure and tissue distribution of matrilin-3, a filament-forming extracellular matrix protein expressed during skeletal development. J Biol Chem 275:3999–4006. https://doi.org/10.1074/jbc.275.6.3999
Piecha D, Wiberg C, Mörgelin M, Reinhardt DP, Deák F, Maurer P, Paulsson M (2002) Matrilin-2 interacts with itself and with other extracellular matrix proteins. Biochem J 367(Pt 3):715–721. https://doi.org/10.1042/BJ20021069
Mann HH, Ozbek S, Engel J, Paulsson M, Wagener R (2004) Interactions between the cartilage oligomeric matrix protein and matrilins. Implications for matrix assembly and the pathogenesis of chondrodysplasias. J Biol Chem 279:25294–25298. https://doi.org/10.1074/jbc.M403778200
Budde B, Blumbach K, Ylöstalo J, Zaucke F, Ehlen HW, Wagener R, Ala-Kokko L, Paulsson M, Bruckner P, Grässel S (2005) Altered integration of matrilin-3 into cartilage extracellular matrix in the absence of collagen IX. Mol Cell Biol 25:10465–10478. https://doi.org/10.1128/MCB.25.23.10465-10478.2005
Wiberg C, Klatt AR, Wagener R, Paulsson M, Bateman JF, Heinegård D, Mörgelin M (2003) Complexes of matrilin-1 and biglycan or decorin connect collagen VI microfibrils to both collagen II and aggrecan. J Biol Chem 278:37698–37704. https://doi.org/10.1074/jbc.M304638200
Huang X, Birk DE, Goetinck PF (1999) Mice lacking matrilin-1 (cartilage matrix protein) have alterations in type II collagen fibrillogenesis and fibril organization. Dev Dyn 216(4–5):434–441
Nicolae C, Ko YP, Miosge N, Niehoff A, Studer D, Enggist L, Hunziker EB, Paulsson M, Wagener R, Aszodi A (2007) Abnormal collagen fibrils in cartilage of matrilin-1/matrilin-3-deficient mice. J Biol Chem 282:22163–22175. https://doi.org/10.1074/jbc.M610994200
Li P, Fleischhauer L, Nicolae C, Prein C, Farkas Z, Saller MM, Prall WC, Wagener R, Heilig J, Niehoff A et al (2020) Mice lacking the matrilin family of extracellular matrix proteins develop mild skeletal abnormalities and are susceptible to age-associated osteoarthritis. Int J Mol Sci 21:666. https://doi.org/10.3390/ijms21020666
Roeder BA, Kokini K, Voytik-Harbin SL (2009) Fibril microstructure affects strain transmission within collagen extracellular matrices. J Biomech Eng 131:031004. https://doi.org/10.1115/1.3005331
Wells RG (2013) Tissue mechanics and fibrosis. Biochim Biophys Acta 1832:884–890. https://doi.org/10.1016/j.bbadis.2013.02.007
Frank C, McDonald D, Shrive N (1997) Collagen fibril diameters in the rabbit medial collateral ligament scar: a longer term assessment. Connect Tissue Res 36:261–269. https://doi.org/10.3109/03008209709160226
Cox TR, Erler JT (2011) Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer. Dis Model Mech 4:165–178. https://doi.org/10.1242/dmm.004077
Acknowledgements
We thank the SingHealth Advanced Bioimaging Core Facilities (Singapore) for facilitating the transmission electron microscopy.
Funding
This research was supported by a SERI-Lee Foundation Pilot Grant (R1582/81/2018), NMRC Senior Investigator Clinician Scientist Award (NMRC/CSA-SI/0001/2015) and grants from the Singapore National Research Foundation under its Translational and Clinical Research (TCR) Program (NMRC/TCR/008-SERI/2013). Animal studies were partially funded by the SERI core grant (NMRC/CG/015/2013). All grants were administered by the Singapore Ministry of Health’s National Medical Research Council.
Author information
Authors and Affiliations
Contributions
LFS conceptualized, designed, and performed research, analyzed and interpreted data, and wrote the paper; SWLC, LZT, XT, and GHFY performed research; GHFY and TTW edited the manuscript.
Corresponding authors
Ethics declarations
Ethics approval and consent to participate
This study was approved by the Institutional Animal Care and Use Committee (IACUC) and treated in accordance with the Association for Research in Vision and Ophthalmology (ARVO) Statement on the Use of Animals in Ophthalmic and Vision Research.
Consent for publication
Not applicable.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Seet, LF., Chu, S.W., Toh, L.Z. et al. Valproic acid modulates collagen architecture in the postoperative conjunctival scar. J Mol Med 100, 947–961 (2022). https://doi.org/10.1007/s00109-021-02171-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00109-021-02171-2